More General News
View Older Stories View Newer Stories-
Take-Two sees annual bookings below revised estimates as 'GTA VI' delay weighs
-
Meta delays release of its 'Behemoth' AI model, WSJ reports
-
FDA plans to review chemicals in US food supply, official says
-
Trump announces $14.5 billion Etihad order for 28 Boeing planes with GE engines
-
Trump administration to audit billions in energy grants awarded under Biden
-
Coinbase says it strongly believes US SEC investigation should not continue
-
Chubb Corp. (CB) Raises Quarterly Dividend 6.6% to $0.97; Approves Buyback of $5 Billion
-
Coreweave signs new $4 billion deal with OpenAI, filing shows
-
Analysts raise price targets on CoreWeave after blowout Q1, despite CapEx concerns
-
Rubrik rating cut: Mizuho says stock is now fairly valued
-
Trump Targets Billions In Energy Grants For New Round Of Audits - Bloomberg
-
US business inventories barely rise in March
-
Analysts see long-term upside in Alibaba despite earnings miss
-
US manufacturing output falls in April on weak auto production
-
Petrobras upgraded to Buy at Jefferies as cost-cutting improves risk-reward
-
Here are 3 key reasons why markets are rallying
-
Tech rally in U.S. and China stocks gaining traction as tariffs ease
-
Roth MKM starts Rubrik at Buy; Mizuho downgrades on valuation concerns
-
Fed's Powell: Strategy around both jobs and inflation needs to be reconsidered
-
Boeing stock target raised at Wolfe after 'a big beautiful order' from Qatar
-
Wall Street mixed on Burberry as UBS upgrades, Deutsche Bank downgrades the stock
-
CoreWeave shares end lower as OpenAI deal fails to calm spending worries
-
Deere beats second-quarter estimates on cost cuts, trims annual profit forecast
-
Dick's Sporting to buy Foot Locker for $2.4 billion to fight soft demand
-
Powell's lean to job market under microscope as Fed revisits strategy
-
DXC Technology (DXC) To Offer Equity Award of $44.85M to CEO Raul Fernandez
-
Cisco lifts annual forecast on AI boost, names insider Patterson as new CFO
-
US FDA approves AbbVie's drug for a type of lung cancer
-
Lockheed Martin anticipates sooner-than-expected F-35 award
-
S&P 500’s recovery has legs, as market shifts to ’show me’ from ’scare me’: BMO
-
Netflix says ad-supported service has 94 million subscribers
-
HSBC to cut 10% of its workforce in France
-
President Donald J. Trump Secures Historic $1.2 Trillion Economic Commitment in Qatar
-
China pauses some measures on US entities following tariff truce
-
Uber bets on affordability with shared fixed-route rides, expanded passes
-
Qatar Airways orders 160 Boeing twin-aisle jets during Trump visit
-
Midwest Boutique Out Positive on Home Depot (HD), Says Management Containing Headwinds
-
AbbVie, Merck cut to Neutral at Citi
-
Take Two stock target raised at Jefferies despite GTA VI delay
-
Wall Street analysts downgrade UnitedHealth after guidance removal
-
AI chipmaker AMD unveils $6 billion buyback plan
-
The U.S. market is expensive and unlikely to continue making new highs: BCA
-
Momentum traders are ’in no rush’ to add to their long positions: UBS
-
OPEC expects slower 2025 oil supply growth from rivals after price drop
-
ECB supervisors press banks on dollar funding over Trump concerns, sources say
-
Be underweight U.S. equities, neutral on the Magnificent 7: Deutsche Bank
-
Exclusive-Ketchup maker Kraft Heinz investing $3 billion upgrading US manufacturing
-
FAA holds meeting with US airlines to cap Newark flights
-
Novo Nordisk strikes $2.2 billion deal with Septerna to develop new obesity treatments
-
SMCI stock jumps on DataVolt deal
